Literature DB >> 27959408

Involvement of xanthine oxidase and paraoxonase 1 in the process of oxidative stress in nonalcoholic fatty liver disease.

Bing Wang1, Rui-Ning Yang1, Yue-Rong Zhu1, Ji-Cheng Xing1, Xiao-Wei Lou1, Yu-Jie He1, Qi-Long Ding2, Ming-Yue Zhang3, Hong Qiu1.   

Abstract

Xanthine oxidase (XOD) and paraoxonase 1 (PON1) are important enzymes in redox reactions in vivo, and are predominantly synthesized by the liver. The aim of the present study was to investigate the redox state in nonalcoholic fatty liver disease, and determine the association between the activities of XOD and PON1 and the severity of NAFLD. Sprague‑Dawley rats were randomly divided into control, model and α‑lipoic acid (high and low dose) groups. The rats in the NAFLD model were induced by feeding a high fat diet for 12 weeks and the in vitro cell model of hepatocyte steatosis was induced by treating L‑02 cells with oleic acid for 24 h. The body weight, liver function, lipid and oxidative stress indices, and histological features of the liver were examined in the rats. Compared with the control group, the rats in the NAFLD model group showed impaired liver function, lipid disorders and damage from oxidative stress. The serum activity of XOD increased significantly from the 4th week and was markedly higher, compared with that in the control group, reaching a peak in the 12th week. The activity of PON1 was negatively correlated with that of XOD. Compared with the control cells, the activity of XOD and levels of free‑fatty acids were significantly higher, and the activity of PON1 was significantly lower in the NAFLD L‑02 cell model. All the above indicators were significantly improved by treatment with the antioxidant, α‑lipoic acid. The activities of XOD and PON1 may be promising as markers in a noninvasive approach for detecting the severity of NAFLD clinically. α‑lipoic acid had protective effects on the NAFLD rats, and the potential mechanism may be associated with the inhibition of oxidative stress and lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27959408     DOI: 10.3892/mmr.2016.6025

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  9 in total

Review 1.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

2.  Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol.

Authors:  Eline H van den Berg; Eke G Gruppen; Richard W James; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2018-11-19       Impact factor: 5.922

3.  Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival.

Authors:  Zheng Yu; Qifeng Ou; Fan Chen; Jiong Bi; Wen Li; Jieyi Ma; Rongchang Wang; Xiaohui Huang
Journal:  J Transl Med       Date:  2018-11-26       Impact factor: 5.531

4.  Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease.

Authors:  Mircea Vasile Milaciu; Ștefan Cristian Vesa; Ioana Corina Bocșan; Lorena Ciumărnean; Dorel Sâmpelean; Vasile Negrean; Raluca Maria Pop; Daniela Maria Matei; Sergiu Pașca; Andreea Liana Răchișan; Anca Dana Buzoianu; Monica Acalovschi
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

5.  Hyperglycemia induces key genetic and phenotypic changes in human liver epithelial HepG2 cells which parallel the Leprdb/J mouse model of non-alcoholic fatty liver disease (NAFLD).

Authors:  Robin C Su; Apurva Lad; Joshua D Breidenbach; Thomas M Blomquist; William T Gunning; Prabhatchandra Dube; Andrew L Kleinhenz; Deepak Malhotra; Steven T Haller; David J Kennedy
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

6.  Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.

Authors:  Kazuhiko Kotani; Jun Watanabe; Kouichi Miura; Alejandro Gugliucci
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

7.  Lung injury induced by short-term mechanical ventilation with hyperoxia and its mitigation by deferoxamine in rats.

Authors:  Xiao-Xia Wang; Xiao-Lan Sha; Yu-Lan Li; Chun-Lan Li; Su-Heng Chen; Jing-Jing Wang; Zhengyuan Xia
Journal:  BMC Anesthesiol       Date:  2020-08-01       Impact factor: 2.217

8.  Lipoic Acid Exacerbates Oxidative Stress and Lipid Accumulation in the Liver of Wistar Rats Fed a Hypercaloric Choline-Deficient Diet.

Authors:  Lidia V Kravchenko; Ilya V Aksenov; Nikolay S Nikitin; Galina V Guseva; Ludmila I Avrenyeva; Nikita V Trusov; Anastasia S Balakina; Victor A Tutelyan
Journal:  Nutrients       Date:  2021-06-10       Impact factor: 5.717

9.  Effects of dexmedetomidine on the function of distal organs and oxidative stress after lower limb ischaemia-reperfusion in elderly patients undergoing unilateral knee arthroplasty.

Authors:  Sunshan Lu; Xingtong Chen; Qian Chen; Zhen Cahilog; Lili Hu; Yan Chen; Jian Cao; Jiaolin Ning; Bin Yi; Kaizhi Lu; Jianteng Gu
Journal:  Br J Clin Pharmacol       Date:  2021-05-06       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.